Drug Trial Radar · NCT03363854
Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3
Last checked: Nov 20, 2026Latest source record: Mar 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
380
Actual
Start
Feb 22, 2018
Primary completion
Mar 8, 2019
Study completion Sep 26, 2019
Sponsor
- Lead sponsor
- LEO PharmaIndustry
- Sponsor type
- Industry
- First posted
- Dec 6, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary objective: To demonstrate that tralokinumab in combination with topical corticosteroids (TCS) is superior to placebo in combination with TCS in treating moderate-to-severe atopic dermatitis (AD). Secondary objectives: To evaluate the efficacy of tralokinumab in combination with TCS on severity and extent of AD, itch, and health-related quality of life compared with placebo in combination with TCS. To assess the safety of tralokinumab in combination with TCS when used to treat moderate-to-severe AD for 32 weeks.
Conditions
- Atopic Dermatitis
Interventions
TralokinumabDrug
Tralokinumab is a human recombinant monoclonal antibody of the IgG4 subclass that specifically binds to human IL-13 and blocks interaction with the IL-13 receptors. It is presented as a liquid formulation for subcutaneous (SC) administration.
PlaceboDrug
Placebo contains the same excipients in the same concentration only lacking tralokinumab.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Participants With Investigator's Global Assessment (IGA) Score of 0 (Clear) or 1 (Almost Clear) at Week 16Time frame: Week 16
- Participants Achieving at Least 75% Reduction in Eczema Area and Severity Index (EASI) at Week 16Time frame: Week 16
Locations
66 sites in 8 countries. Site status is shown where the registry gives one.
University of Alabama-Birmingham
Birmingham, Alabama
California Dermatology & Clinical Research Institute
Encinitas, California
First OC Dermatology
Fountain Valley, California
Center for Dermatology Clinical Research
Fremont, California
Dermatology Research Associates
Los Angeles, California
Clinical Science Institute
Santa Monica, California
Danbury Clinical Research
Danbury, Connecticut
International Dermatology Research
Miami, Florida
L & C Professional Medical Research
Miami, Florida
Lenus Research & Medical Group
Sweetwater, Florida
Olympian Clinical Research
Tampa, Florida
Medical Dermatology Specialists
Atlanta, Georgia
Northwestern University
Chicago, Illinois
Indiana Clinical Trials Center
Plainfield, Indiana
Study Center
Bangor, Maine
Respiratory Medicine Research
Ypsilanti, Michigan
Mount Sinai West Dermatoogy
New York, New York
Wake Research
Raleigh, North Carolina
Dermatologists of Greater Columbus
Bexley, Ohio
Oregon Dermatology & Research
Portland, Oregon
National Allergy and Asthma Research, LLC
North Charleston, South Carolina
University Hospital Antwerp
Antwerp, Belgium
Universitair ziekenhuis Brussel
Brussels, Belgium
Cliniques Universitaires St-Luc
Brussels, Belgium
LEO Pharma Investigational Site
Loverval, Belgium
Institute for Skin Advancement
Calgary, Alberta, Canada
Skin Care Centre
Vancouver, British Columbia, Canada
Maritime Medical Research Centre
Bathurst, New Brunswick, Canada
Eastern Canada Cutaneous Research
Halifax, Nova Scotia, Canada
CCA Medical Research
Ajax, Ontario, Canada
Simcoderm Medical and Surgical Dermatology Centre
Barrie, Ontario, Canada
DermEdge Research
Mississauga, Ontario, Canada
York Dermatology Center
Richmond Hill, Ontario, Canada
Research Toronto
Toronto, Ontario, Canada
XLR8 Medical Research
Windsor, Ontario, Canada
Interdisciplinary Study Association GmbH
Berlin, Germany
St. Josef-Hospital, Ruhr-Universitet
Bochum, Germany
Klinik und Poliklinik für Dermatologie und Allergologie
Bonn, Germany
Klinikum der Johann Wolfgang Goethe-Universität Klinik
Frankfurt am Main, Germany
MensingDerma Research GmbH
Hamburg, Germany
Showing 40 of 66 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.